Drug · DIN 02224690
LASIX
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 9, 2014; first marketed April 21, 1997.
- Drug Identification Number (DIN)
- 02224690
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Furosemide C03CA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FUROSEMIDE | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 7, 2006: NOC 7871New Drug Submission (NDS) · Manufacturer name change
- August 15, 2000: NOC 1160New Drug Submission (NDS)
Other DINs named LASIX
- DIN 02224704 · Cancelled Post Market